Expert Video - How is biomarker testing done and what biomarkers are looked at when deciding on treatment for ovarian cancer?
A tissue sample called a biopsy can be tested for proteins and other substances called biomarkers that indicate the presence and type of ovarian cancer. This is called biomarker testing or tumor testing. Dr. Jayathi Lea of the University of Texas Southwestern Medical Center explains that laboratory tests can find ovarian cancer biomarkers including CA125, HRD, bikunin, VEGF, and more. She discusses the importance of early tumor or biomarker testing, when and why it should be repeated, and how it can improve outcomes by helping doctors choose the best treatment for the type of ovarian cancer.
This educational activity has been developed by the National Ovarian Cancer Coalition in collaboration with Mechanisms in Medicine Inc.
This activity is supported by educational grants from: Alkermes plc, AstraZeneca Pharmaceuticals LP, Clovis Oncology, Inc., Eisai Inc., Foundation Medicine, Inc., Genentech, a Member of the Roche Group, GSK, ImmunoGen, Inc., Merck & Co, Inc., Novartis, Novocure Inc., Pfizer, Inc.
This website is part of the Animated Patient® series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.